Targeting CD40 with dapirolizumab pegol: a new treatment for systemic lupus erythematosus

Ronald van Vollenhoven1

  • 1Amsterdam UMC, Amsterdam 1009, Netherlands; Department of Rheumatology, Semmelweis University, Budapest, Hungary.

Abstract

No abstract available in PubMed .

Related Concept Videos